These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9352172)

  • 1. Adjunctive therapy for acute myocardial infarction.
    Alexander J
    Curr Opin Cardiol; 1997 Sep; 12(5):453-8. PubMed ID: 9352172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying the results of large clinical trials in the management of acute myocardial infarction.
    Sweeney JP; Schwartz GG
    West J Med; 1996 Mar; 164(3):238-48. PubMed ID: 8775936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Betablocker therapy in acute myocardial infarction].
    Danchin N; Angioi M; Preiss JP; Jacquemin L; Houriez P
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():43-7. PubMed ID: 9749276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myocardial infarction.
    Danchin N; Urban P; De Benedetti E
    Clin Evid; 2002 Jun; (7):11-35. PubMed ID: 12230636
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
    Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic reperfusion strategies for the treatment of ST-segment elevation myocardial infarction.
    Young JJ; Kereiakes DJ
    Rev Cardiovasc Med; 2003; 4(4):216-27. PubMed ID: 14668689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
    Zahn R; Schuster S; Schiele R; Seidl K; Voigtländer T; Meyer J; Hauptmann KE; Gottwik M; Berg G; Kunz T; Gieseler U; Jakob M; Senges J
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):127-33. PubMed ID: 10348528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological aspects of secondary prevention post-MI].
    Schrör K
    Z Kardiol; 2004; 93 Suppl 1():I1-3. PubMed ID: 15021997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comments on the contribution by B. Noll. Aspirin and heparin in acute myocardial infarct].
    Möckel M; Störk T
    Internist (Berl); 1995 Nov; 36(11):1101-4. PubMed ID: 8543449
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium-channel blockers as adjuvant therapy postthrombolysis.
    Boden WE
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S102-6. PubMed ID: 1724997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute myocardial infarction: does the type of hospital make a difference? PPAMI Study Group.
    George E; Hunsberger S; Savitha D; Pais P
    Indian Heart J; 1999; 51(2):161-6. PubMed ID: 10407543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.